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Introduction {#sec1}
============

X inactivation is an epigenetic mechanism that evolved in mammals to equalize the dosage of X-linked genes in XX females relative to XY males. One of the two X chromosomes in early XX embryos is randomly selected and modified to form a transcriptionally repressed heterochromatic structure, the Barr body. Once established, the inactive state is stably inherited through subsequent cell divisions ([@bib35]).

Key features of the inactive X chromosome (Xi) include the acquisition (or loss) of specific histone post-translational modifications, DNA methylation of X-linked gene promoters, and changes in the higher-order chromosome folding, resulting in compaction and inaccessibility of the underlying chromatin (reviewed in [@bib26]). The establishment of Xi modifications is initiated by a 17 kb long non-coding (lnc) RNA, Xist (X Inactive Specific Transcript), which localizes in *cis* along the length of the Xi elect (reviewed in [@bib11]). Accordingly, the X inactivation model serves as an important paradigm for understanding the role of chromatin modifications and non-coding RNA in the regulation of gene expression in development.

A key goal toward understanding the mechanism of X inactivation has been to define chromatin-modifying factors that are directly recruited by Xist RNA. The best-studied example to date is the Polycomb system, comprising the Polycomb-repressive complexes PRC1 and PRC2. PRC1 and PRC2, respectively, catalyze the histone modifications H2A lysine 119 ubiquitylation (H2AK119u1) and H3 lysine 27 di-/tri-methylation (H3K27me2/3), both of which are highly enriched on Xi ([@bib20], [@bib46], [@bib50], [@bib55]). Early studies proposed that PRC2 complexes are directly bound by the A-repeat of Xist RNA ([@bib57]), a critical element required for chromosome silencing ([@bib56]). PRC1 recruitment was attributed to recognition of PRC2-mediated H3K27me3 by the canonical PRC1 subunit CBX according to the classical model for hierarchical recruitment of Polycomb complexes ([@bib10]). However, building on the recent discovery that both PRC1 and PRC2 complexes can bind to pre-existing H2AK119u1 ([@bib4], [@bib6], [@bib17], [@bib18], [@bib32]), we have found that a specific non-canonical PRC1 complex, PCGF3/5-PRC1, initiates Xist-dependent Polycomb recruitment ([@bib1]). Thus, H2AK119u1 catalyzed by PCGF3/5-PRC1 recruits PRC2, and also other non-canonical PRC1 complexes in response to accumulation of Xist RNA. Deletion of PCGF3/5-PRC1 results in female-specific embryo lethality and attenuates Xist-mediated silencing ([@bib1]).

An important question that remains unresolved is how Xist RNA recruits PCGF3/5-PRC1 and whether this is direct or mediated by co-factors. In this study, we map the critical sequence for Polycomb recruitment to a 600 nt element, the Xist RNA Polycomb Interaction Domain (XR-PID), which encompasses the Xist RNA B-repeat. We show that XR-PID is required for Xist-dependent deposition of H2AK119u1 and H3K27me3, efficient Xist-mediated gene silencing, and inactive chromosome inaccessibility. We identify hnRNPK as the critical XR-PID binding protein that directs the recruitment of PCGF3/5-PRC1. Conclusively, we demonstrate that in the absence of XR-PID, synthetic tethering of hnRNPK is sufficient for Polycomb recruitment by Xist RNA.

Results {#sec2}
=======

XR-PID---A Minimal Region of Xist RNA Required for Polycomb Recruitment {#sec2.1}
-----------------------------------------------------------------------

Previous work defined a 3.9 kb region of mouse Xist RNA, designated XN, required for recruitment of PRC1 and PRC2 ([@bib19], [@bib1]). The XN region includes three tandem repeat sequence clusters, the F, B, and C repeats ([Figure 1](#fig1){ref-type="fig"}A). Analysis of Xist sequences in different mammalian species indicated that the B-repeat, being highly conserved ([@bib42]), is a candidate for mediating Polycomb recruitment. To test this possibility, we deleted a 0.6 kb region spanning the B-repeats in a doxycycline inducible Xist transgene. The deletion, XistΔXEv, encompasses the entire B-repeat array and a small part of the C-repeat located immediately downstream ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). Stable cell lines were derived by transfecting the XistΔXEv or full-length (FL) Xist into P4D7, a *Mus domesticus* (129S1) x *Mus castaneus* F1 hybrid mouse embryonic stem cell (mESC) line ([@bib1]). Use of a hybrid genetic background facilitated analysis of Xist-mediated silencing (see below). Xist transgene expression was induced concurrent with initiation of mESC differentiation, in this case for 24 hr. ImmunoFISH analysis revealed complete loss of Xist-dependent recruitment of H2AK119u1 and H3K27me3 deposition ([Figures 1](#fig1){ref-type="fig"}B, 1C, and [S1](#mmc1){ref-type="supplementary-material"}B). Enrichment of PRC1 and PRC2 subunits was also undetectable, as determined by immunofluorescence (IF) analysis ([Figures S1](#mmc1){ref-type="supplementary-material"}D and S1E). These findings were confirmed using an independent XistΔXEv mESC cell line (data not shown). Henceforth we refer to this critical element as the Xist RNA Polycomb Interaction Domain (XR-PID).Figure 1A 0.6 kb Element, XR-PID, Mediates Polycomb Recruitment by Xist RNA(A) Schematic illustrating the XistΔXEv deletion (encompassing XR-PID) relative to FL-Xist. The location of Xist tandem repeats A--F is indicated. The XistΔXN transgene described previously is shown for comparison.(B) Examples of immunoFISH analysis illustrating presence or absence of H2AK119u1 foci (arrowheads), following 24 hr induction of Xist transgenes. Images are stacks of six consecutive Z sections with insets showing a single section. Nuclei outlines determined from DAPI stain are indicated with dashed line in inset. Scale bar indicates 5 μm.(C) Quantitative analysis of a single FL-Xist and XistΔXEv cell line based on scoring Xist RNA domains for presence or absence of H2AK119u1 or H3K27me3. Error bars represent SD for at least three biological replicates with a sample of n \> 100 for each replicate.(D) As in (A). Green shading highlights B-repeat element.(E) As in (B).(F) As in (C). ^∗∗^p \< 0.001 relative to FL-Xist (2 tailed Student's t test).

To further define the XR-PID, we established a simplified assay, making use of EvXist, a short form of Xist RNA that corresponds to the first 3.9 kb of Xist exon I, and which encompasses the A-, F-, and B-repeat and a small part of the C-repeat present in XR-PID ([Figure 1](#fig1){ref-type="fig"}D). A previous study demonstrated that EvXist is sufficient to form Xist RNA domains, albeit less robustly than FL-Xist RNA ([@bib56]). We obtained similar results and found that EvXist recruits both PRC1 and PRC2, as determined by IF for H2AK119u1 and H3K27me3, respectively ([Figures 1](#fig1){ref-type="fig"}E, 1F, and [S1](#mmc1){ref-type="supplementary-material"}C). We then analyzed a series of modified EvXist constructs, as summarized in [Figure 1](#fig1){ref-type="fig"}D. Deletion of the critical XR-PID sequence abolished PRC1/PRC2 recruitment, again with no effect on Xist RNA domain formation ([Figures 1](#fig1){ref-type="fig"}D--1F and [S1](#mmc1){ref-type="supplementary-material"}C). Replacement of the XR-PID with an inverted fragment also abolished Polycomb recruitment ([Figures 1](#fig1){ref-type="fig"}D and 1F), indicating that the observed effect is not attributable to a reduction in the spacing of flanking elements. Deletions of EvXist spanning other regions, notably the F-repeats, did not affect Polycomb recruitment ([Figures 1](#fig1){ref-type="fig"}D and 1F). Deletions spanning the A-repeat, or a short region between the A-repeat and F-repeat ([Figure 1](#fig1){ref-type="fig"}D), disrupted Xist localization and therefore could not be tested for Polycomb recruitment (data not shown).

The XR-PID has a 0.3 kb proximal region comprising 32 tandem copies of the B-repeat motif, and a 0.3 kb distal region spanning most of the first three of 14 copies of the C-repeat ([Figure S1](#mmc1){ref-type="supplementary-material"}A). We therefore analyzed the effect of deleting the proximal or distal XistΔXEv regions in the context of the EvXist construct ([Figure 1](#fig1){ref-type="fig"}D). As shown, deletion of the proximal region entirely abolished Polycomb recruitment ([Figure 1](#fig1){ref-type="fig"}F). Conversely, Polycomb recruitment occurred, albeit at a moderately reduced level, in the absence of the distal region ([Figure 1](#fig1){ref-type="fig"}F). These observations indicate that the B-repeat array has a central role in Polycomb recruitment.

XR-PID Is Required for Xist-Mediated Chromosome Silencing {#sec2.2}
---------------------------------------------------------

We went on to assess the contribution of the XR-PID to Xist-mediated silencing by comparing allelic expression ratios in cell lines expressing either FL-Xist, XistΔXR-PID, XistΔXN (the large deletion previously shown to abolish Polycomb recruitment; [@bib19], [@bib1]), or XistΔSX (a deletion of the A-repeat element previously shown to be required for Xist-mediated silencing; [@bib56]). To account for variations in silencing related to different transgene integration sites (each mESC line has a unique integration event that can occur on any chromosome), we analyzed replicates for two independent cell lines for each of the different constructs (only a single line was analyzed for XistΔSX). We applied 4-thiouridine labeling followed by sequencing (4sU-seq) ([@bib49]), to enrich for nascent RNA in order to exploit *Mus castaneus* versus 129S1 single nucleotide polymorphisms (SNPs) in introns. Typically, we observed ∼40% of reads overlapping with introns (data not shown). To quantify Xist-mediated silencing, we developed a computational method to generate a repression score (RS) for each gene, or a median RS value for genes within a defined window or whole chromosome, based on normalized allelic ratios (see materials and methods). RS analysis of 4sU-seq data revealed the chromosome and allele on which the Xist transgene was integrated (see, for example, [Figure 2](#fig2){ref-type="fig"}A), verified in each case by DNA FISH analysis of metaphase spreads ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B).Figure 2The XR-PID Element Contributes to Transcriptional Silencing Mediated by Xist RNA(A) RS distribution across all autosomes in two biological replicates, for two cell lines expressing FL-Xist (left) versus XistΔXR-PID (right), following a 72 hr induction of the transgenes.(B) RS distribution in continuous 10 Mb windows across chromosome 3 for FL-Xist (left) and chromosome 2 for XistΔXR-PID (right). Purple dots represent the RS for each gene. Blue boxes indicate maximum RS window.(C) UCSC genome browser tracks showing the *Cnn3* locus (left) and *Dstn* locus (right) after induction of FL-Xist or XistΔXR-PID, respectively. Gray tracks represent no-dox control. Red and blue are two biological replicates with 72 hr dox treatment. The active allele (129S1) and inactive allele (Cast) are indicated. Chromosomal location of *Cnn3* and *Dstn* is indicated with a red bar on the chromosome ideogram above each example.(D) Comparison of RS in windows centered on maximal RS for cells harboring FL-Xist and Xist transgenes as indicated. The color and area of circles indicate the size and gene number within the region, respectively.(E) RS comparison (% of genes) in the 10 Mb of maximum silencing windows depicted in (B). RS range is as indicated.

Time course experiments over 24--72 hr using a cell line expressing FL-Xist RNA indicated that chromosome silencing is highly correlated between individual time-points ([Figures S2](#mmc1){ref-type="supplementary-material"}C--S2E). There was a marginal increase in repression over time, with maximal levels seen at 72 hr ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D), and this time point was therefore used for subsequent experiments. We went on to compare chromosome silencing induced by FL-Xist, XistΔXN, and XistΔXR-PID ([Figures 2](#fig2){ref-type="fig"}B--2E). Silencing by FL-Xist was, as expected, efficient, and extended along the length of the chromosome. An example, P4D7F4, in which the transgene integrated on the *Mus castaneus* allele of chromosome 3, showed significant repression of the majority of genes (∼96%; 630 out of 659) ([Figures 2](#fig2){ref-type="fig"}B and 2C). XistΔXN and XistΔXR-PID lines, however, showed reduced repression efficiency. Thus, in a representative XistΔXR-PID cell line ([Figures 2](#fig2){ref-type="fig"}B and 2C), significant repression was seen for approximately half of the genes on the chromosome (∼49%; 565 out of 1,144).

To quantify the silencing efficiency of different constructs, we compared the RS within defined windows in which highest levels of silencing were observed ([Figure 2](#fig2){ref-type="fig"}D). We further determined the proportion of genes with RS in the range 0.1--1 within the maximal 10 Mb window for each cell line ([Figure 2](#fig2){ref-type="fig"}E). The results from these analyses clearly illustrate reduced silencing using XistΔXN and XistΔXR-PID compared to FL-Xist transgenes. Given that deletion of PCGF3/5-PRC1 attenuates silencing to a similar degree ([@bib1]), we infer that the observed effect is attributable to the requirement for XR-PID for Xist-dependent PRC1/PRC2 recruitment. For XistΔSX, in which the critical silencing element, the A-repeat, is deleted, we were unable to identify the transgene-bearing chromosome on the basis of allelic expression ratios, consistent with expectations. We did, however, identify the integration site of the single XistΔSX cell line using DNA FISH ([Figure S2](#mmc1){ref-type="supplementary-material"}B), and here we were able to retrospectively discern a region with a low level of allelic repression ([Figures 2](#fig2){ref-type="fig"}D and 2E). This observation is consistent with a previous report indicating that XistΔSX transgenes repress to a limited degree ([@bib47]). Levels of induced Xist RNA using different constructs/time-points were comparable ([Figures S2](#mmc1){ref-type="supplementary-material"}F and S2G), indicating that this variable does not contribute significantly to observed differences in silencing efficiency.

A similar analysis of cell lines carrying the truncated EvXist transgenes revealed chromosome-wide silencing, but at a reduced level, similar to XistΔXN/XistΔXR-PID ([Figures 2](#fig2){ref-type="fig"}D and 2E). For cell lines expressing EvXistΔXR-PID, we were unable to identify the transgene-bearing chromosome before DNA-FISH analysis ([Figure S2](#mmc1){ref-type="supplementary-material"}B), indicating that silencing was strongly abrogated. To test this more definitively, we used homologous recombination to target a single copy of EvXist or EvXistΔXR-PID transgenes into the *Col1a1* homing site on chromosome 11 ([@bib5]) in P4D7 mESCs, and performed 4sU-seq and RS analysis ([Figures 3](#fig3){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}A). Because the EvXist and EvXistΔXR-PID transgenes are at the same site, we were able to derive a calibrated (c) RS score, which precisely accounts for the statistical significance of RS, over random mono-allelic expression of genes located on the same chromosome (see [STAR Methods](#sec4){ref-type="sec"}). We made use of cRS to directly compare EvXist and EvXistΔXR-PID-mediated silencing. For EvXist, 45% of genes (454 out of 1,010) were significantly repressed, with the majority (373 out of 454) being located on the distal half of chromosome 11 ([Figure 3](#fig3){ref-type="fig"}B). The cRS within the 10 Mb maximum silencing region was similar to the RS seen with EvXist random integrants ([Figure 2](#fig2){ref-type="fig"}D). However, for EvXistΔXR-PID, silencing was strongly reduced, with only 10% of genes (100 out of 1,010) being significantly repressed ([Figures 3](#fig3){ref-type="fig"}B--3F and [S3](#mmc1){ref-type="supplementary-material"}B--S3D). Moreover, in the majority of cases, repression by EvXistΔXR-PID was at a lower level than that seen in EvXist-expressing cells ([Figures 3](#fig3){ref-type="fig"}E, [S3](#mmc1){ref-type="supplementary-material"}C, and S3D). Examples of EvXist and EvXistΔXR-PID-mediated silencing of specific loci, *Syngr2-Tk1* and *Sept9*, located in the 10 Mb maximum silencing region, are illustrated in [Figures 3](#fig3){ref-type="fig"}F and [S3](#mmc1){ref-type="supplementary-material"}E. Transgenic Xist RNA levels were similar ([Figure S3](#mmc1){ref-type="supplementary-material"}F).Figure 3XR-PID-Mediated Silencing Analyzed using EvXist, a Truncated Xist Transgene(A) Schematic for site-specific integration of a single copy of EvXist or EvXistΔXR-PID into the *Col1a1* locus (in red) on chromosome (chr) 11 (top). Heatmap shows the RS in each chromosome for both replicates (rep), using EvXist or EvXistΔXR-PID (bottom).(B) RS distribution in continuous 10 Mb windows across chromosome 11, following 72 hr induction of single-copy EvXist (top) or EvXistΔXR-PID (bottom) transgenes. Purple dot represents the RS for each gene. The position of the *Col1a1* locus is indicated.(C) RS comparison between EvXist and EvXistΔXR-PID in windows centered on the region of maximum silencing. The color and area of dots indicate the region size and gene number, respectively.(D) RS comparison (% of genes) between EvXist and EvXistΔXR-PID cell lines in the 10 Mb of maximum silencing windows depicted in (B). The RS was grouped into four categories, indicated by the graded color.(E) Scatterplot showing the differences of the calibrated (c) RS for 454 repressed genes in EvXist and EvXistΔXR-PID. The axis represents log2-transformed cRS.(F) Heatmap illustrating RS of each gene ranked by genomic coordinates on chromosome 11 for both biological replicates of EvXist and EvXistΔXR-PID cells (left). The *Syngr2-Tk1* locus, indicated by red lines, is shown in the upper chromosome ideogram. RS is indicated, and q value for both *Syngr2* and *Tk1* is 0 in EvXist cells and 0.036 and 0.611, respectively, in EvXistΔXR-PID cells. Data for no dox (untreated) and for two replicates (rep) of 72 hr induction (red and blue) are shown. Active (129S1) and inactive (Cast) alleles are labeled (right).

Deletion of XR-PID Abrogates Xist-Dependent Loss of Chromatin Accessibility {#sec2.3}
---------------------------------------------------------------------------

Polycomb complexes mediate gene silencing either directly, by inhibiting gene transcription ([@bib52], [@bib58]), or indirectly, by modulating higher-order chromatin structure or compaction ([@bib24], [@bib31], [@bib34]). High-resolution mapping of Xist-dependent H3K27me3 shows equal enrichment over gene promoters, gene bodies, and intergenic regions ([@bib9], [@bib39], [@bib45]), which is difficult to reconcile with direct effects on transcription. With this in mind, we investigated whether expression of the Xist transgenes lacking the XR-PID element affected parameters associated with higher-order chromatin organization, specifically chromatin accessibility. Initially we measured chromatin accessibility using the Assay for Transposase-Accessible Chromatin followed by ImmunoFISH (ATAC-see) ([@bib13]). Expression of FL-Xist transgenes established inaccessible chromatin domains ([Figure 4](#fig4){ref-type="fig"}A), as reported previously ([@bib13]). In marked contrast, we failed to detect loss of chromatin accessibility in response to expression of the XistΔXR-PID transgene ([Figure 4](#fig4){ref-type="fig"}B). Equivalent results were obtained using cell lines with independent transgene integration sites, indicating that the difference relates to the functional properties of the different transgenes rather than the site of integration.Figure 4XR-PID Is Required for Reduced Chromatin Accessibility over Xist Domains(A and B) Individual examples illustrating Xist RNA-FISH combined with ATAC-see. The nuclei (DAPI staining) are outlined with a dotted line with Xist domains indicated (arrowhead). Scale bar indicates 5 μm. Fluorescence intensity of the ATAC-see signal overlapping Xist and total nuclear signal were measured for two independent cell lines for FL-Xist (A) and XistΔXR-PID transgenes. Bar graphs represent average values for three biological replicates (n \> 20) for each independent cell line. Error bars represent SD. ^∗^p \< 0.05 (paired Student t test).(C) Chromatin accessibility changes upon FL-Xist induction on chromosome 3. The red bar on the ideogram indicates maximum silencing regions. The chr3-wide accessibility changes from XistΔXR-PID expressing cells, in which the Xist transgene is on chr2, serves as a control. The p value was calculated using Mann-Whitney test.(D) Chromatin accessibility changes in the presence (blue) or absence (red) of FL-Xist expression.(E) Chromatin accessibility changes upon XistΔXR-PID induction on chromosome 2. Red bar on the ideogram indicates maximum silencing regions. The chr2-wide accessibility changes from FL-Xist transgene cells (chr3) provide a control. The p value was calculated using Mann-Whitney test.(F) As in (D) for XistΔXR-PID.

To increase the resolution of our analysis, we performed allelic ATAC-seq ([@bib8], [@bib27]) on representative cell lines with either FL-Xist or XistΔXR-PID transgenes, located on chromosomes 3 and 2, respectively. As illustrated in [Figures 4](#fig4){ref-type="fig"}C--4F and [S4](#mmc1){ref-type="supplementary-material"}A, FL-Xist expression significantly reduces chromatin accessibility at sites across the entire chromosome, similar to previous reports ([@bib27]). In contrast, expression of the XistΔXR-PID transgene resulted in little or no change in chromatin accessibility. This effect was evident for all key regulatory elements, promoters, enhancers, and CTCF-binding sites ([Figures S4](#mmc1){ref-type="supplementary-material"}B--S4D). Together, these results suggest that Xist-dependent Polycomb activity is critical for chromatin compaction to facilitate transcriptional repression.

A Proteomic Screen Identifies hnRNPK as a B-Repeat RNA-Binding Protein {#sec2.4}
----------------------------------------------------------------------

We went on to investigate the mechanism for Polycomb recruitment by the B-repeat element. Thus, we established a proteomic screening strategy using *in vitro*-transcribed and biotinylated RNA templates to identify RNA-binding proteins (RBPs) in mESC extracts that interact directly with Xist B-repeat RNA ([Figures 5](#fig5){ref-type="fig"}A, 5B, and [S5](#mmc1){ref-type="supplementary-material"}A--S5E). We engineered a 0.8 kb construct that includes both the A-repeat and B-repeat elements, together with flanking sequences, and additionally, mutant constructs in which either the A-repeat or B-repeat was replaced with non-functional sequences. Thus, in the case of the A-repeat we used a synthetic mutant construct previously shown to disrupt A-repeat specific function ([@bib56]), whereas for the B-repeat we used the non-functional inverted B-repeat sequence ([Figure 1](#fig1){ref-type="fig"}D).Figure 5hnRNPK Binds Xist B-Repeat(A and B) Schematic (A) of the proteomic screening strategy using different *in vitro* transcribed Xist constructs, indicated in (B). Proteins in nuclear extract (gray shapes) that bind *in vitro*-transcribed RNA with incorporated biotin (filled lollipop) were captured by UV cross-linking and then purified using streptavidin beads (large filled circle) prior to analysis by MS.(C) Overlap with Xist-interacting partners identified in independent biochemical ([@bib14]) and genetic ([@bib41]) screens.(D and E) Scatterplots representing abundance of factors interacting preferentially with the A-repeat (D) or the B-repeat (E) elements of Xist by quantitative MS. Q value was calculated across two biological replicates.(F) Western blot shows levels of hnRNPK before and after 24, 48, and 72 hr siRNA treatment. Histone H3 was used as a loading control. Bar chart quantifies immunoFISH analysis of H2AK119u1 and Xist RNA co-localization in cells treated with hnRNPK or scrambled (control) siRNA. Data are from two independent siRNA transfections, each with three biological replicates (n \> 50). Error bars represent SD across all biological replicates.(G) UCSC track displaying hnRNPK iCLIP data ([@bib15]) aligned to Xist RNA sequence. The correspondence with the XR-PID and specifically with the B-repeat core motif is highlighted in light blue. The most prominent peak of hnRNPK binding is enlarged below (red) and aligned to the genomic sequence of the XR-PID across several mammalian species. The consensus B-repeat core sequence spanning the region is also represented.

We performed an MS proteomic analysis to identify bound RBPs following UV crosslinking and purification of the biotinylated RNA with its covalently bound proteins. High-confidence interactors obtained using the unmodified template ([Table S1](#mmc2){ref-type="supplementary-material"}) showed significant overlap with Xist-interacting proteins defined in prior *in vivo* proteomic ([@bib14]) and genetic ([@bib41]) screens ([Figure 5](#fig5){ref-type="fig"}C). We went on to define A-repeat- and B-repeat-specific binding proteins by performing label-free comparative MS analysis ([Figures 5](#fig5){ref-type="fig"}D and 5E). Thus, we identified several proteins that bound to RNA templates in an A-repeat-specific manner ([Figure 5](#fig5){ref-type="fig"}D; [Table S1](#mmc2){ref-type="supplementary-material"}). Among these were four factors identified in Xist genetic and proteomic screens as above: Rbm15, an RBP that interacts specifically with the A-repeat to function in Xist-mediated silencing ([@bib41], [@bib43]); the transcriptional repressor Myef2; and the splicing factors Luc7l3 and Sf3. We also identified proteins that bound preferentially to template RNA in the presence of functional B-repeat ([Figure 5](#fig5){ref-type="fig"}E; [Table S1](#mmc2){ref-type="supplementary-material"}). Notably, we identified hnRNPK, an Xist-binding protein previously implicated both in Xist-mediated silencing and recruitment of PRC1 and PRC2 ([@bib14]). hnRNPK binds preferentially to cytidine tracts in RNA ([@bib53]), which is a characteristic of the conserved short tandem B-repeat consensus ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Consistent with this finding, PCBP1/2, two related RNA-binding proteins with a preference for cytidine tracts were also among the factors that bind preferentially to B-repeat RNA ([Figure 5](#fig5){ref-type="fig"}E).

We went on to further validate hnRNPK as a candidate for mediating PRC1/PRC2 recruitment. Consistent with prior work, we found that RNAi-mediated knockdown of hnRNPK reduces H2AK119u1 deposition in response to induction of a FL Xist RNA transgene ([Figures 5](#fig5){ref-type="fig"}F and [S5](#mmc1){ref-type="supplementary-material"}F). Additionally, a previously published iCLIP analysis of hnRNPK binding sites mapped a major peak in Xist exon I ([@bib15]). Re-analysis of these data relative to the location of tandem repeats in Xist RNA reveals close overlap with the B-repeat element ([Figure 5](#fig5){ref-type="fig"}G). A low level of hnRNPK enrichment extends into the C-repeat region, consistent with our observation that the C-repeat elements present in XR-PID contribute to Polycomb recruitment to a limited degree ([Figure 1](#fig1){ref-type="fig"}F).

Biochemical Interaction of hnRNPK with PCGF3/5-PRC1 {#sec2.5}
---------------------------------------------------

The aforementioned experiments suggest that hnRNPK plays an important role in Polycomb recruitment by the B-repeat of Xist RNA. hnRNPK is a multi-functional protein implicated in several processes, including chromatin modification, transcription, splicing, and translation (reviewed in [@bib7]). Interaction studies have identified a large number of hnRNPK partner proteins, including the PRC2 protein EED ([@bib7]). We were interested to determine if hnRNPK interacts with PRC1 proteins, notably the PCGF3/5-PRC1 complex that initiates Polycomb recruitment by Xist RNA ([@bib1]). To investigate this possibility, we performed co-immunoprecipitation (coIP) analysis in mESCs. Thus, we established mESC lines stably expressing eGFP-hnRNPK ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B) and then carried out coIP analysis using a high-specificity single-chain *Lama alpaca* antibody against eGFP to detect subunits of either PRC1 or PRC2. As illustrated in [Figure 6](#fig6){ref-type="fig"}A, RING1B and RYBP, core subunits of PRC1, co-immunoprecipitated with hnRNPK, whereas the PRC2 core subunits EED and EZH2 did not. This result accords with our recent findings linking PRC1 to Xist-dependent Polycomb recruitment ([@bib1]).Figure 6hnRNPK Interacts Directly with PCGF3/5-PRC1(A) Western blots illustrating eGFP pull-down of PRC1 and PRC2 proteins (as indicated) in cells expressing hnRNPK-eGFP. Loaded were 0.1% of the input (IN), 0.1% of the flowthrough (FT), and 10% of the pull-down (IP).(B) RING1B pull-down repeated using cell lines expressing hnRNPK-eGFP deletion variants as indicated in schematic. Loading is as in (A).(C) Western blots illustrating pull-down of recombinant PCGF3-PRC1, but not PCGF2-PRC1, using recombinant GST-hnRNPK. A Coomassie brilliant blue-stained gel of the complexes used in the assay is shown above. Loaded were 0.1% of flowthrough (FT), 20% of eluate (E), and 33% of bead bound (B).

hnRNPK has three KH domains that mediate RNA-binding and a KI domain, located between KH2 and KH3 ([Figure 6](#fig6){ref-type="fig"}B), which has been implicated in binding to diverse interaction partners ([@bib7]). To test which region of hnRNPK interacts with PRC1, we established mESC lines stably expressing eGFP-hnRNPK constructs with overlapping deletions ([Figures S6](#mmc1){ref-type="supplementary-material"}C--S6E) and then performed coIP for RING1B. As shown in [Figure 6](#fig6){ref-type="fig"}B, the minimal region required for specific coIP of RING1B maps to the KI domain of hnRNPK.

We predicted that the interaction of hnRNPK and PRC1 would be specific to the PCGF3/5-PRC1 complex, required to initiate Polycomb recruitment by Xist RNA. Consistent with this idea, we were able to demonstrate coIP of PCGF5 with GFP-hnRNPK ([Figure S6](#mmc1){ref-type="supplementary-material"}F). To further validate this finding, and to determine if the interaction is direct, we established a pull-down assay using recombinant proteins expressed in *E. coli*. Thus, we purified hnRNPK as a GST fusion protein ([Figure S6](#mmc1){ref-type="supplementary-material"}G) and assembled PRC1 complexes with the core subunits RING1B and RYBP, and then either PCGF3, representative of PCGF3/5-PRC1, or PCGF2 and PCGF6, representative of other canonical and non-canonical PRC1 complexes ([Figures S6](#mmc1){ref-type="supplementary-material"}H--S6J). Using stringent conditions, we observed robust interaction between hnRNPK and PCGF3-PRC1, but not PCGF2-PRC1 ([Figure 6](#fig6){ref-type="fig"}C) or PCGF6-PRC1 ([Figure S6](#mmc1){ref-type="supplementary-material"}J). Given that RING1B and RYBP are present in all three recombinant PRC1 complexes, we conclude that specificity of the interaction with hnRNPK is conferred by the presence of the PCGF3 subunit.

Tethering hnRNPK to XistΔXR-PID Restores Polycomb Recruitment {#sec2.6}
-------------------------------------------------------------

Together, our results suggest that hnRNPK binds to XR-PID and then directly recruits PCGF3/5-PRC1 to initiate chromosome-wide Polycomb recruitment. To further test this model, we established an experimental system to complement the XR-PID deletion by synthetically tethering hnRNPK. Thus, we made use of the BglG/Bgl stem loop (SL) tether, which has been used previously to tag Xist RNA with mCherry for imaging experiments ([@bib41]). We developed a construct for expressing BglG-hnRNPK-eGFP fusion protein, and as a control BglG-eGFP fusion protein, in P4D7 mESCs, co-transfected with an inducible XistΔXR-PID transgene tagged with an array of 18 copies of the BglSL ([Figure 7](#fig7){ref-type="fig"}A). We derived several independent cell lines expressing either BglG-eGFP or BglG-hnRNPK-eGFP. IF analysis of GFP demonstrated that both fusion proteins localize efficiently to single nuclear foci following induction of Xist RNA ([Figure S7](#mmc1){ref-type="supplementary-material"}A).Figure 7Tethering hnRNPK Is Sufficient for Xist-Dependent Polycomb Recruitment(A) Schematic illustrating the hnRNPK-tethering experiment.(B) Examples of ImmunoFISH detection of Xist RNA and H2AK119u1 using BglG-hnRNPK or BglG-eGFP. Wide-field images represent stacks of 10 consecutive Z sections. Arrows indicate Xist domains. Insets showing enlarged individual cells are single z sections. Scale bar indicates 5 μm.(C) Bar graphs illustrate quantification for H2AK119u1 and H3K27me3 domains overlapping Xist in independent cell lines (clones) of each named construct. Error bars represent SD across at least three biological replicates (n \> 100).(D) Example as in (B) for BglG-ΔKI hnRNPK.(E) RS comparison between two independent BglG-hnRNPK cell lines in windows centered on the region of maximum silencing. The color and area of dots indicate the region size and gene number, respectively. Green and pink gradients represent the range of RS previously measured for FL and XistΔXR-PID lines, respectively.(F) RS comparison between two independent BglG-hnRNPK cell lines in the 10 Mb of maximum silencing windows. The RS was grouped into four categories, indicated by the graded color.(G) Model illustrating molecular pathway for Polycomb recruitment by Xist RNA.

To test the ability of the fusion proteins to mediate Polycomb recruitment, we analyzed co-localization of Xist transgene RNA and H2AK119u1 ([Figures 7](#fig7){ref-type="fig"}B--7D) or H3K27me3 ([Figures 7](#fig7){ref-type="fig"}C and [S7](#mmc1){ref-type="supplementary-material"}B--S7D), 24 hr after transgene induction. Strikingly, localization of BglG-hnRNPK-eGFP fusion resulted in Xist-dependent deposition of both H2AK119u1 and H3K27me3 ([Figures 7](#fig7){ref-type="fig"}B, 7C, and [S7](#mmc1){ref-type="supplementary-material"}B). Detection of H2AK119u1/H3K27me3 domains varied somewhat in different hnRNPK-BglG cell lines ([Figure 7](#fig7){ref-type="fig"}C), and this appeared to correlate with the relative size of Xist RNA domains ([Figure S7](#mmc1){ref-type="supplementary-material"}E). Recruitment of the BglG-eGFP fusion protein alone did not lead to either H2AK119u1 ([Figures 7](#fig7){ref-type="fig"}B and 7C) or H3K27me3 ([Figures S7](#mmc1){ref-type="supplementary-material"}C and [7](#fig7){ref-type="fig"}C) deposition, also confirmed in independently derived mESC lines ([Figure 7](#fig7){ref-type="fig"}C).

As a further test of our findings, we engineered a deletion of the hnRNPK KI domain, implicated in interaction with PCGF3/5-PRC1 ([Figure 6](#fig6){ref-type="fig"}B), into the BglG-hnRNPK-eGFP fusion protein. Stable mESC lines generated by co-transfecting this construct, together with an inducible BglSL-XistΔXR-PID transgene, were then analyzed for eGFP localization ([Figure S7](#mmc1){ref-type="supplementary-material"}A) and for Xist-dependent H2AK119u1 ([Figures 7](#fig7){ref-type="fig"}C and 7D) and H3K27me3 ([Figures S7](#mmc1){ref-type="supplementary-material"}D and [7](#fig7){ref-type="fig"}C). Polycomb recruitment to Xist domains was undetectable in independently derived mESC lines.

Finally, to determine if tethering hnRNPK to BglSL-XistΔXR-PID RNA enhances Xist-mediated silencing, we performed allelic 4sU RNA-seq analysis on two of these cell lines. As shown in [Figures 7](#fig7){ref-type="fig"}E, 7F, and [S7](#mmc1){ref-type="supplementary-material"}F--S7I, the RS values obtained were similar to those found for FL-Xist and were significantly higher than with XistΔXR-PID Xist transgenes. Together, these results substantiate that hnRNPK binding to the B-repeat recruits PCGF3/5-PRC1 to initiate Xist-dependent recruitment of Polycomb complexes ([Figure 7](#fig7){ref-type="fig"}G).

Discussion {#sec3}
==========

The results of this study reveal key steps in the pathway for recruitment of Polycomb-repressive complexes by Xist RNA, illustrated in [Figure 7](#fig7){ref-type="fig"}G. We suggest that tandemly arranged copies of the cytidine rich B-repeat element recruit multiple hnRNPK subunits. hnRNPK, through its KI domain, interacts directly with the PCGF3/5 subunit of the PCGF3/5-PRC1 complex, which initiates the Polycomb cascade. hnRNPK-bound PCGF3/5-PRC1 may act directly to modify underlying chromatin, or alternatively may dissociate and diffuse to nearby sites. Given the evidence that Xist RNA is anchored to the nuclear matrix ([@bib16], [@bib29]), and as a consequence localizes to a compartment that is spatially separated from chromatin ([@bib51]), we favor the latter proposal. Subsequent steps, involving recognition of PCGF3/5-PRC1-mediated H2AK119u1 by other PRC1 complexes and by PRC2 ([@bib18], [@bib1]), and downstream of this, recognition of H3K27me3 by canonical PRC1 complexes ([@bib25], [@bib40]), occur as described previously.

Our findings are broadly in accord with prior analysis of Polycomb recruitment by Xist RNA. Thus, the pathway described herein accounts for the close correlation between Polycomb-mediated chromatin modifications and sites of enrichment of Xist RNA, reported in several previous studies ([@bib9], [@bib23], [@bib37], [@bib39], [@bib45]). Additionally, the requirement for ongoing Xist expression ([@bib33], [@bib38], [@bib46]) can be attributed to PCGF3/5-PRC1 recruitment through interaction with hnRNPK bound to the B-repeat element of Xist RNA. Although this link was suggested previously, based on identification of hnRNPK and PRC1 proteins among factors that bind Xist RNA either directly or indirectly ([@bib14]), our findings define the key sequence elements and underlying molecular interactions. It should be noted that our experiments were performed using in tissue culture models with Xist transgenes located on autosomes, and we cannot rule out that additional factors make a contribution in the context of X inactivation *in vivo*.

The consensus motif of the Xist B-repeat has a tract of two to four consecutive cytidines, which accords with the preferred binding site for hnRNPK, comprising three separate cytidine patches bound by each of three KH domains ([@bib44]). There are 32 copies of the B-repeat motif, which could theoretically allow simultaneous binding of up to ten hnRNPK subunits on a single molecule of Xist RNA. High hnRNPK occupancy may serve to amplify PCGF3/5-PRC1 recruitment to a level sufficient to initiate the Polycomb cascade. This proposal is supported by hnRNPK iCLIP analysis ([@bib15]), which defines a strong peak precisely corresponding to the B-repeat. The iCLIP data also indicate a broad region marked by a low-level hnRNPK occupancy, correlating with the location of the C-repeat. Accordingly, we find that deletion of the three copies of the C-repeat present in the XR-PID region marginally reduces Polycomb recruitment in the context of the short EvXist transgenes. It is interesting to note that the 115 nt C-repeat consensus includes two separate 3--5 nt cytidine tracts that could potentially mediate hnRNPK binding, albeit less optimally, given their frequency and spacing. Unlike the B-repeat, the core C-repeat consensus is not amplified in the Xist gene in human and other mammals ([@bib42]), indicating that the B-repeat is the key conserved element for Polycomb recruitment by Xist RNA.

Polycomb recruitment in X inactivation has been reported to occur in marsupial mammals ([@bib12], [@bib36]), despite the fact that an independently evolved non-coding RNA, Rsx, functions as the master regulator ([@bib28]). Rsx also comprises several tandemly repeated sequence elements, and it is plausible that one of these has evolved to bind hnRNPK. There may also be other examples of non-coding RNAs, or for that matter coding RNAs, that utilize hnRNPK to concentrate Polycomb-repressive complexes in *cis*. Thus, in future studies it will be important to examine the relationship between hnRNPK RNA-binding sites and Polycomb occupancy across the genome.

In our recent study defining the role of PCGF3/5-PRC1 in the Xist Polycomb recruitment pathway, we reported that chromosome silencing is significantly reduced in the absence of both PRC1 and PRC2 ([@bib1]). Accordingly, in this study we observed a similar reduction in silencing following deletion of the XR-PID element. We were able to examine this effect in detail by using hybrid mESCs, and by analyzing the EvXist construct with or without XR-PID, targeted in single copy into a homing site on chromosome 11. Chromosome silencing by EvXist was seen to be relatively robust and widespread, albeit reduced relative to FL Xist transgenes. Deletion of XR-PID strongly reduced silencing, an observation that was somewhat surprising, given that the A-repeat, previously defined as the principal element required for Xist-mediated silencing ([@bib56]), is still present. A possible explanation for this result is that in the absence of functions conferred by Xist elements downstream of the EvXist region, Polycomb recruitment plays a more critical role in supporting A-repeat-mediated silencing. This may involve a role for Polycomb in stabilizing A-repeat-mediated silencing or, alternatively, may relate to a role for Polycomb in compacting the chromosome to facilitate the spread of A-repeat-mediated silencing, supported by our observation that deletion of XR-PID reduces loss of chromatin accessibility associated with Xist expression.

Given that significant chromosome silencing is detected in the absence of XR-PID, presumably due to the presence of the A-repeat and associated factors, it is perhaps surprising that deletion of this element results in such a dramatic loss of the decrease in chromosome accessibility. Indeed, a previous study showed that Xist-dependent loss of chromatin accessibility is abrogated, albeit less dramatically, when the A-repeat is deleted ([@bib27]). Thus, in future studies it will be important to further investigate the interplay of A-repeat and XR-PID pathways, both in Xist-dependent gene silencing and in chromatin accessibility changes.

In conclusion, this study, together with our recent findings, provides key insights into the molecular mechanism for Polycomb recruitment by Xist RNA and moreover highlights a key role for Polycomb in Xist-mediated chromosome silencing. Given the potential importance of lncRNA in guiding chromatin modification, this mechanism provides a model for further studies on lncRNA function both in development and in disease.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Antibodies for immunofluorescence assaysCommercialSee [Table S4](#mmc1){ref-type="supplementary-material"}Antibodies for western blottingCommercialSee [Table S4](#mmc1){ref-type="supplementary-material"}Antibodies for immunoprecipitation assaysCommercialSee [Table S4](#mmc1){ref-type="supplementary-material"}**Bacterial and Virus Strains**DH5α Competent CellsThis studyN/A**Biological Samples**DMEMLife Technologycat\# 12634-010OPTI-MEMLife Technologiescat\# 11058021Fetal Calf SerumSeralabN/AChicken SerumLife Technologiescat\# 16110082LIFIn house producedN/A**Chemicals, Peptides, and Recombinant Proteins**KaryoMAX ColcemidLife Technologiescat\# 15210-040Dimethyl sulfate (DMS)Sigma Aldrichcat\# D1863094-thiouridine (4sU)Sigma Aldrichcat\# T4509DoxycyclineClonetechcat\# 631311EZ-Link HPDP-BiotinSigma Aldrichcat\# PI21341**Critical Commercial Assays**Nick translation kitAbbott Diagnosticscat\# 7J0001HiScribe T7 High Yield RNA Synthesis KitNEBcat\# E2040SuMacs Streptavidin KiTMiltenyicat\# 130-074-101RNeasy MinElute Cleanup KitQIAGENcat\# 74204TruSeq Stranded Total RNA Sample Preparation Kit with Ribo-Zero GoldIlluminacat\# RS-122-2301**Deposited Data**4sU-seq, ATAC-seqThis studyGEO: [GSE103370](ncbi-geo:GSE103370){#intref0010}4sU-seq, ATAC-seq summaryThis studySee [Table S2](#mmc3){ref-type="supplementary-material"}Mendeley Data, part IThis study[https://doi.org/10.17632/p8835bsb8g.1](10.17632/p8835bsb8g.1){#intref0015}Mendeley Data, part IIThis study[https://doi.org/10.17632/dfrbvsdcrf.1](10.17632/dfrbvsdcrf.1){#intref0020}**Experimental Models: Cell Lines**Mouse ESC: C57BL/6JJcl x 129/SvJcl (P4D7)[@bib41]N/AMouse ESC: C57BL/6JJcl x 129/SvJcl expressing Xist WT and mutThis studySee [Figure S2](#mmc1){ref-type="supplementary-material"}Mouse ESC: C57BL/6JJcl x 129/SvJcl expressing Xist-bgl[@bib41]N/AMouse ESC: pgk 12.1[@bib61]N/A**Oligonucleotides**Oligonucleotides for conventional and LIC cloning of hnRNPK and Xist cDNAThis studySee [Table S3](#mmc1){ref-type="supplementary-material"}gRNA for CRISPR-mediated HRThis studySee [Table S3](#mmc1){ref-type="supplementary-material"}Oligonucleotides for Tn5 assemblyThis study; [@bib13]See [Table S3](#mmc1){ref-type="supplementary-material"}**Recombinant DNA**pTRE-tight-Xist[@bib41]N/ApCAG-IRES-PuroThis studyN/ApSpCas9(BB)-2A-Puro (PX459) V2.0Addgenecat\# 62988pCol1a1-EvXistThis studyN/A**Software and Algorithms**Samtools[@bib60]<http://samtools.sourceforge.net/>Bedtools[@bib48]<http://bedtools.readthedocs.io/en/latest/>Bowtie2[@bib59]<http://bowtie-bio.sourceforge.net/bowtie2/index.shtml>SNPsplitBabraham Institute<http://www.bioinformatics.babraham.ac.uk/projects/SNPsplit/>STAR[@bib22]<https://github.com/alexdobin/STAR>Htseq[@bib2]<http://www-huber.embl.de/HTSeq/doc/overview.html>RS AnalysisThis study<https://github.com/guifengwei/XCI>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Neil Brockdorff (<neil.brockdorff@bioch.ox.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

ES cells were grown in ES cell medium, which consisted of Dulbecco's Modified Eagle Medium (DMEM, from Life Technologies) supplemented with 9% fetal calf serum (FCS, from Seralab), 2 mM L-glutamine, 1x non-essential amino acids, 50 μM 2-mercaptoethanol, 50 g/mL penicillin/streptomycin (all from Life Technologies) and LIF- conditioned medium, made in house, at a concentration equivalent to 1000U/mL. Non-differentiating ES cells were grown on tissue culture dishes coated with PBS + 0.1% gelatine. EC10 medium consisted of DMEM, supplemented with 9% FCS, 2 mM L-glutamine, 1x non-essential amino acids, 50 μΜ 2-mercaptoethanol and 50 g/mL penicillin/streptomycin. Cells were grown at 37°C in a humid atmosphere with 5% CO~2~. Cells were passaged using 0.05% trypsin-EDTA (Life Technologies) with 2% Chicken Serum (Life Technologies) and frozen in FCS + 10% DMSO.

Xist expression driven by TetOn promoter was induced by adding doxycycline (1.5-2 μg/mL) to the culture medium for 24 hr to 3 days depending on the experiment. To achieve differentiation, ES cells were plated at a low density (0.6·10ˆ6 cells) in 14cm non-gelatineised tissue culture dishes in EC10 medium, and grown in LIF-depleted conditions for 72 hr.

Methods Details {#sec4.4}
---------------

### Plasmids {#sec4.4.1}

Xist cDNA was inserted into a pTRE-tight vector as previously described ([@bib41]). Deletions of Xist DNA were obtained by digesting the plasmid with relevant restriction enzymes, and, where required, re-inserting restriction fragments derived from the same plasmid. In detail, ΔSX Xist was generated using MluI (cDNA position after TSS: 1bp) and XhoI (cDNA position after TSS position: 1026bp); ΔXN Xist was generated using XhoI (cDNA position after TSS: 1026bp) and NcoI (cDNA position after TSS position: 4882bp); ΔXEv Xist was generated using XbaI (cDNA position after TSS: 2884bp) and EcoRV (cDNA position after TSS position: 3560bp); EvXist was generated truncating Xist after EcoRV (cDNA position after TSS: 3560bp); ΔXR-PID EvXist was generated cutting EvXist with XbaI (cDNA position after TSS: 2684bp) and EcoRV (cDNA position after TSS position: 3560bp); Prox XR-PID EvXist was generated by re-inserting the XbaI fragment (cDNA position after TSS: 2684bp-2884bp) into ΔXR-PID EvXist; Dist XR-PID EvXist was generated by re-inserting the XbaI-EcoRV fragment (cDNA position after TSS: 2884bp-3560bp) into ΔXR-PID EvXist; Inv XR-PID EvXist was generated by re-inserting the XbaI fragment (cDNA position after TSS: 2684bp-2884bp) into ΔXR-PID EvXist, but with inverted orientation; ΔF EvXist was generated by re-ligation of the vector following digestion of EvXist with BlpI (cDNA position after TSS: 1256bp) and AccI (cDNA position after TSS position: 2198bp). For the ΔXEv-Xist-Bgl system, 18 repeats of the Bgl stem loop motif were fused to Xist, as in ([@bib41]).

Coding sequences for hnRNPK (full-length and truncated) were amplified from cDNA obtained from 129S1 wt cell line using primers listed in the Resource Table. These sequences were inserted by LIC cloning into a modified pCAG-IRES-Puro mammalian expression plasmid between the coding sequences for a C- or N-terminal enhanced GFP (eGFP) and a 3′ IRES sequence that precedes a puromycin resistant cassette. For the hnRNPK-BglG fusion, the same coding sequences were inserted by LIC cloning into the pCAG-IRES-Puro mammalian expression plasmid between the coding sequence for a C-terminal enhanced GFP (eGFP) fused to the BglG protein, and a 3′ IRES sequence that precedes puromycin resistant gene. BglG was PCR-amplified from a previously described vector ([@bib41]) using the primers listed in in the Resource Table, and inserted in the pCAG vector by Gibson Assembly (NEB). For *in vitro* transcription studies, functional versus non-functional A-repeats described in ([@bib56]) were kindly provided by Anton Wutz, cloned into a pBluescript plasmid (Stratagene) and fused to the B-repeat sense and antisense sequence cut from Xist cDNA using restriction sites. In detail, the vector was digested with XhoI, and the B-repeat fragment, excised with XbaI, was blunt-ended and inserted in either orientation. For CRISPR-Cas9-facilitated homologous recombination of Xist into the *Col1a1* locus ([@bib3]), the targeting vector described in ([@bib5]) was adapted by shortening the homology arms to 0.8 kb on either side, adding MluI/PacI sites in the MCS (primers listed in in the Resource Table) from pTre-tight, and inserting EvXist in the MluI/PacI restriction sites, in the presence or absence of the XR-PID region. Correct targeting was verified by Southern Blot, as in ([@bib5]).

### Conventional cloning {#sec4.4.2}

Assembly of vectors and inserts was obtained by either sticky-end or blunt-end cloning after gel extraction of purified plasmid-cut DNA using the Zymoclean Gel DNA Recovery Kit (Zymoresearch). Ligation was performed at 16°C for 2 hr, 10°C for 2 hr, and 4°C overnight with T4 DNA Ligase (Promega). In case of non-directional sticky-end cloning, vector DNA was treated with 1U of CIAP (GIBCO) at 37°C for 5 min prior to gel extraction. Blunt-ending was performed by treating DNA with 20U of T4 DNA Polymerase (ThermoScientific) for 30 min at 16°C.

### Ligation independent cloning (LIC) {#sec4.4.3}

5 μg of vector plasmid was linearized with the appropriate restriction enzyme. The vector DNA was isolated by gel extraction using the Zymoclean Gel DNA Recovery Kit (Zymoresearch). Insert DNA was amplified by PCR and purified by gel extraction using the same kit. Vector and insert were processed by T4 DNA polymerase (ThermoScientific) in the presence of 2 mM dGTP (vector) and 2 mM dCTP (insert) for 30 min at 22°C. After heat-inactivation of the polymerase (20 min, 75°C), samples were purified using the DNA Clean & Concentrator-5 kit (Zymoresearch). Vector and insert were incubated using a range of ratios (3:1-1:6) in 2 μL total volume for 30 min at 25°C and introduced into bacteria as below.

### Gibson assembly {#sec4.4.4}

Depending on the specific cloning, either two different PCR products, or a PCR product and a linearized vector were isolated by gel extraction using the Zymoclean Gel DNA Recovery Kit (Zymoresearch). 50 ng of donor vector was incubated in a 1:3 ratio with the insert in the presence of 10 μL of Gibson Assembly Master Mix (NEB) in 20 μL total volume at 25°C for 60 min. 5 μL of the reaction were introduced into bacteria.

### Bacterial transformation {#sec4.4.5}

Competent DH5α (fhuA2 lac(del)U169 phoA glnV44 80' lacZ(del)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17) cells were generated in-house using a protocol based on ([@bib30]). Bacteria were thawed on ice and 2 μL DNA of ligation mixture was added. DNA was mixed with bacteria by gentle flicking of the tube and incubated on ice for 25-30 min. Bacteria were heat-shocked at 42°C for 30 s and allowed to recover on ice for 2 min, before being incubated in 10 volumes of LB solution at 37°C for 1 hr. Bacteria were then spread on high salt (10 mg NaCl/mL) LB agar plates containing the appropriate antibiotic for selection.

### Mouse lines and ESC line derivation {#sec4.4.6}

A modified version of pR26/P'nlsrtTA construct in which the puromycin resistance cassette was replaced by a hygromycin resistance cassette, was electroporated into hybrid C57BL/6JJcl x 129/SvJcl cells, to target rtTA into the constitutively active ROSA26 locus as previously described ([@bib54]). Targeting was verified by Southern blot analysis using unique sequence probes. All cell lines carrying an inducible Xist randomly integrated into the genome were generated by co-transfection into rtTA-expressing cells with either a puromycin or neomycin expression cassette, as explained below. Positive clones were verified by RNA-FISH for Xist RNA upon doxycycline treatment. hnRNPK-eGFP fusion cell lines were obtained by transfection of the relevant construct into PGK 12.1 cells, and positive clones verified by western blot. hnRNPK-eGFP-BglG, ΔKI-hnRNPK-eGFP-BglG, and BglG-eGFP cell lines, were obtained by co-transfection into rtTA-expressing cells of either vector in combination with Xist-Bgl, and selected by GFP/Xist ImmunoFISH after doxycycline induction. Single copy EvXist and EvXist ΔXR-PID were obtained by co-transfection of targeting vector expressing a neomycin expression cassette and three different gRNAs (see Resource Table).

### Generation of stable cell lines expressing transgenes {#sec4.4.7}

All transgenic ES cells in this study are stable expressing lines. To generate stable ES cell lines, cells were plated in 6-well plates on feeders at a density of 1-2·10^6^ cells/well, a day before transfection. Cells were transfected using Lipofectamine 2000 (Life Technologies, Invitrogen), according to the manufacturer's instructions. After 24 hr, transfected cells were passaged to 90 mm gelatinised Petri dishes with feeders. Puromycin (1.5-2.5 μg/mL) or G418 (350-500 μg/mL) selections were applied 48 hr after lipofection. Cells were grown for 10-12 days under selection, with medium being changed every day. Individual ES colonies were picked and expanded for further screening. For CRISPR-assisted homologous recombination, 1 μg of each gRNA was added to the lipofection cocktail, and antibiotic selection applied 24 hr after transfection for 48 hr.

### siRNA knock-down {#sec4.4.8}

iGENOME SMARTpools siRNA against hnRNPK were purchased from Dharmacon. Transfection into cells was performed on coverslips with RNAiMAX (Invitrogen), according to the manufacturer's instructions. Xist was induced at the same time as transfection for the 24 hr time-point, otherwise 24 or 48 hr after transfection.

### Metaphase spreads {#sec4.4.9}

Cells were grown in T25 flasks until nearly confluent, and incubated at 37°C with fresh medium containing 1.5 μg/mL ethidium bromide (Roche). After 1 hr and 20 min, colchicine (KaryoMAX Colcemid, Life Technologies) was added to a final concentration of 0.1 μg/mL and incubated for a further 40 min. Cells were then washed in PBS and harvested by trypsinisation at room temperature. After inactivation of the trypsin by addition of medium, cells were pelleted by centrifugation (400 g, 3 min, 25°C). A pellet of 1-2 mm thickness was carefully resuspended in 1 mL hypotonic solution (75 mM KCl) for no more than 5 min. Then 200 μL freshly prepared fixative (75% methanol, 25% Acetic Acid, 4°C) was added drop-wise. The tube was not agitated, but carefully placed in the centrifuge for pelleting (400 g, 3 min, 25°C). Supernatant was removed leaving about 100 μL, used to re-suspend the cells in by gentle flicking. 1 mL of fixative was added to the resuspended cells and incubated overnight at 4°C without agitation. The following day, the cells were carefully resuspended in the same fixative and pelleted as before. The pellet was resuspended in 1.5 mL fixative and pelleted again. This step was repeated twice more. The cell suspension was then dropped onto clean microscope slides and air-dried.

### Genomic DNA extraction {#sec4.4.10}

Cells from a confluent T75 were harvested and resuspended in 1-3 mL lysis buffer (10 mM NaCl, 10 mM Tris-HCl pH 7.5, 10 mM EDTA-NaOH pH 8.0, 0.5% Sodium lauroyl sarcosinate) with proteinase K added to a final concentration of 200 μg/mL. Samples were incubated overnight at 55°C. 1/25 volume of 5 M NaCl and 2.5 volume of ice-cold 100% ethanol were added. After mixing, a visible white cloud of DNA was extracted using a bent pipette tip and transferred to a clean tube containing 1 mL 70% ethanol. DNA was pelleted (16,100 g, 5 min, 4°C) and air-dried. Subsequently the pellet was resuspended in 300-400 μL 10 mM Tris pH 8.5 and the concentration measured by Nanodrop.

### Nuclear extraction and immunoblotting {#sec4.4.11}

Nuclear cell extracts were prepared by harvesting cells and either processing them immediately or snap-freezing them on dry ice and storing them at −80°C, essentially as described in ([@bib21]). In both cases, cell pellets were washed with PBS and resuspended in 10 packed cell volume (PCV) buffer A (10 mM HEPES-KOH pH 7.9, 1.5 mM MgCl~2~, 10 mM KCl, with 0.5 mM DTT, 0.5 mM PMSF, and complete protease inhibitors (Roche) added fresh). After a 10 min incubation at 4°C, cells were collected by centrifugation (1500 g, 5 min, 4°C) and resuspended in 3 PCV of buffer A + 0.1% NP-40 (Sigma). After another 10 min incubation at 4°C, nuclei were collected by centrifugation (400 g, 5 min, 4°C) and resuspended in 1 PCV buffer C (250 mM NaCl, 5 mM HEPES-KOH (pH 7.9), 26% glycerol, 1.5 mM MgCl~2~, 0.2mM EDTA-NaOH, pH 8.0 with complete protease inhibitors (Roche) + 0.5 mM DTT added fresh). 5 M NaCl was added drop-wise to bring the concentration to 350 mM and the mixture was incubated for 1 hr at 4°C with occasional agitation. After centrifugation (16,100 g, 20 min, 4°C), the concentration of the supernatant was quantified using the Bio-Rad Bradford assay and stored at −80°C.

Samples for immunoblotting were diluted in 6xSMASH buffer (50 mM Tris HCl pH 6.8, 10% Glycerol, 2% SDS, 0.02% bromophenol blue, 1% β-mercaptoethanol), boiled for 10 min at 95°C, separated on a polyacrylamide gel, and transferred onto a nitrocellulose membrane by semi-dry transfer (15 V for 50 min). Membranes were blocked by incubating them for 1 hr at room temperature in 10 mL TBS, 0.1% Tween (TBST) with 5% w/v Marvel milk powder. Blots were incubated overnight at 4°C with the primary antibody, washed 4 times for 10 min with TBST and incubated for 40 min with secondary antibody conjugated to horseradish peroxidase. After washing 4 times for 5 min with TBST, bands were visualized using ECL (GE Healthcare).

### Co-immunoprecipitation (CoIP) assays {#sec4.4.12}

In-house GFP nanobodies were prepared by washing 165 μL of M-280 Tosyl-activated Dynabeads (ThermoScientific) twice in buffer A (0.1 M H~2~BO~3~ pH 9.5), before adding 100 μL of GFP-nanobodies (in-house His-affinity purified from pET21b_pelB_VHH24 expression vector, kind gift of Michael Root, Rockefeller University), for a total volume of 150 μL in buffer A. After addition of 100 μL buffer C (0.1 M H~2~BO~3~, 3M (NH~4~)~2~SO~4~), the mixture was incubated at 37°C overnight. The day after, 1 mL of buffer D (0.01 M BSA in PBS) was added, and beads incubated at 37°C for a further 1 hr. Coupled beads were washed twice in buffer E (0.005 M BSA in PBS), resuspended in buffer E to a final concentration of 20 mg/mL, and stored at 4°C.

For the coIP assays, 500 μg of nuclear extract were used and the salt concentration was adjusted to 150 mM NaCl in a 1 mL total reaction volume. Extracts were treated with 250 U Benzonase nuclease (Millipore) for 30 min at 4°C. 100 μg of nanobodies were added and incubated at 4°C overnight. The flowthrough was collected and beads were washed 3 times with 1 mL wash buffer (5mM HEPES-KOH pH 7.9, 1.5 mM MgCl~2~, 26% glycerol, 0.2 mM EDTA, with complete protease inhibitors (Roche) + 0.5 mM DTT added fresh) with 150 mM NaCl, and 3 times with the same wash buffer with 450 mM NaCl. Subsequently beads were boiled in 50 μL SMASH buffer (50 mM Tris HCl pH 6.8, 10% Glycerol, 2% SDS, 0.02% bromophenol blue, 1% β-mercaptoethanol) for 10 min at 95°C. 5 μL of the supernatant was loaded as the IP sample.

### Expression and purification of PRC1 complexes and hnRNPK {#sec4.4.13}

PRC1.2/ PRC1.6 (RING1B C-term His/Strep, RYBP, PCGF2/6) and PRC1.3 (RING1B, RYBP, PCGF3 C-term His/Flag) complexes were cloned into a psT44 vector, co-expressed in ArcticExpress DE3 bacteria cells (Agilent), and purified by nickel affinity chromatography and gel filtration. For each complex: 2 L of 2xTY media was divided into 3 flasks (700 mL each) and each flask was inoculated with 21 mL overnight pre-culture and 50 μg/mL Ampicillin (700 μL). Once inoculated, flasks were placed in an incubator at 30°C (shaker: 220 rpm) and cells are grown until they reached a 0.8-0.9 OD at 600 nm. Cells were then placed at 12°C for 20 min. Expression was induced by adding 0.5 mM IPTG and cells were then left in the incubator at 12°C for 20-24 hr. After incubation, cells were centrifuged for 15 min at 6,000 rpm at 5°C and pellets re-suspended using 20 mL/L (buffer/culture) lysis buffer (20 mM HEPES pH8, 250mM NaCl, 10% glycerol, 0.1% Triton X-100, 1 tablet of protease inhibitors (1/100 mL), 0.25 mg/mL lysozyme). After re-suspension, cells were placed in a 50 mL falcon tube, flash-frozen in liquid nitrogen and stored at −80°C.

For subsequent extraction of each complex, tubes were placed in a water bath at RT. Once cells were defrosted, 10mM MgCl~2~, 5 μg DNase1, 1mM Benzamidine were added and each tube was left to shake gently in the cold for 20 min. Cells were then sonicated 8 times at 80%, 30 s on/30 s off, and centrifuged for 1 hr at 20,000 rpm at 4°C. Supernatant was collected and filtrated into a new 50 mL Falcon tube. 10 mM Imidazole and 2 mL of pre-washed Ni Sepharose 6 Fast Flow beads (GE Healthcare) were added into the supernatant and incubated for 2 hr at 4°C. Supernatant was then placed into a glass column. Flowthrough was collected and tube and beads were washed with 10 CV His buffer A (20 mM HEPES pH7.5, 5% glycerol, 500 mM NaCl, 2mM fresh 2-Mercaptoethanol), 2%--6% His Buffer B (20 mM HEPES pH7.5, 5% glycerol, 500 mM NaCl, 2mM fresh β-mercaptoethanol, 500mM Imidazole), and eluted with 2CV in 10%--60% His Buffer B. Collected fractions were loaded on a 12% Acrylamide SDS-PAGE gel and those containing the complex were pooled together, concentrated to 500 μL using a Sartorius Vivaspin 20 50K Centrifugal Concentrator and run on a gel filtration Superdex 200 Increase 10/300 GL column (GE Healthcare) using an Äktapurifier system (GE Healthcare) (Gel filtration buffer: 20 mM HEPES pH7.5, 5% glycerol, 300 mM NaCl, 2 mM fresh β-mercaptoethanol).

GST-hnRNPK was cloned into a pGEX-KT vector, and similarly expressed and extracted. The protein was then isolated using a GST-Trap HP column (GE Healthcare) on an Äktastart system (GE Haelthcare). In detail, 5 μg/mL DNaseI, 10 mM MgCl~2~, 1 mM benzamidine were added to the cell culture, with shaking at 4°C for 20 min. Cells were then lysed with a French Press at 30 kpsi, and centrifuged at 16,000 rpm for 1 hr at 4°C. The cell lysate was loaded onto the column using a peristatic pump, the column then connected to an Äktastart system (GE Healthcare), was washed with 10 CV Buffer A (20 mM HEPES pH7.5, 5% glycerol, 300 mM NaCl, 500 mM Glucose, 2 mM fresh β-mercaptoethanol, 1 mM EDTA; 0.1% Triton) and eluted with 7 CV Buffer B (20 mM HEPES pH7.5, 5% glycerol, 300 mM NaCl, 500 mM Glucose, 2 mM fresh β-mercaptoethanol; 1 mM EDTA, 0.1% Triton, 10 mM reduced glutathione).

Further purification by Ion Exchange was achieved using a 1 mL HiTrap Q HP column (GE Healthcare). In detail, the sample was diluted to 100 mM NaCl and loaded onto the column, subsequently washed with 5 CV 10% Buffer B, eluted with 10 CV 10 to 100% Buffer B and washed again with 5 CV 100% Buffer B. Final concentration and gel filtration step of the sample were performed as above.

### PRC1-hnRNPK pull-down assays {#sec4.4.14}

PRC1 complexes sample and hnRNPK sample were mixed together to a final concentration of 30 μg of each protein and incubated overnight at 4°C with gentle shaking. The next day 10 μL of pre-washed Glutathione Sepharos HP beads (GE Helathcare) were added to each samples in pull-down buffer (20 mM HEPES, 300 mM NaCl, 5% Glycerol, 0.1% Triton X-100, 250 mM Sucrose, 2 mM β-mercaptoethanol), and incubated for 2 hr at 4°C on a wheel. Beads were spun 2 min at 2,000 rpm at 4°C, and the supernatant (FT) collected. Two wash steps were performed by adding 100 μL of pull-down buffer and spinning for 2 min at 2,000 rpm at 4°C. Supernatant was collected (W1 and W2). The elution was performed by adding 20 μL elution buffer (20 mM HEPES, 300 mM NaCl, 5% Glycerol, 0.1% Triton X-100, 250 mM Sucrose, 2 mM β-mercaptoethanol, 10 mM reduced glutathione), incubating the samples in the same conditions as above for 15-30 min with gentle mixing. Supernatant (E) was collected after spinning for 2 min at 3,000 rpm at 4°C, and a further 20 μL of elution buffer was added, spun for 2 min at 3,000 rpm at 4°C and supernatant collected and added with the previous elution fraction. Beads (B) were also collected by adding 40 μL of pull-down buffer. All collected fractions were diluted in 6xSmash buffer (50 mM Tris.HCl pH 6.8, 10% Glycerol, 2% SDS, 0.02% bromophenol blue, 1% β-mercaptoethanol), incubated for 5min at 95°C and kept at −20°C until western blot assays were performed.

### Immunofluorescence {#sec4.4.15}

Cells were plated on slides or coverslips (13 mm diameter coverslips from VWR), at least a day before the experiment. On the day of the experiment, cells on slides were washed with PBS and then fixed with 2% formaldehyde for 15 min, followed by 5 min of permeabilisation in 0.4% Triton X-100. Cells were briefly washed with PBS before blocking with a 0.2% w/v PBS-based solution of fish gelatine (Sigma) for three periods of 10 min. Primary antibody dilutions were prepared in fish gelatine solution with 5% normal goat or normal donkey serum depending on the secondary antibody used. Primary antibody dilutions are listed in the Resource Table. Cells on slides were incubated with primary antibodies for 1.5 hr in a humid chamber at room temperature. Slides were washed three times in fish gelatine solution. Secondary antibodies were diluted in fish gelatine solution and incubated with cells on slides for 45 min in a humid chamber at 37°C. After incubation, slides were washed twice with fish gelatine and one time with PBS before mounting using Vectashield mounting medium with 4,6-diamidino-2-phenylindole (DAPI). Excess mounting medium was removed and the coverslips were sealed to slides using nail varnish.

### RNA-FISH {#sec4.4.16}

Cells were plated on either slides or coverslips. After washing twice with PBS, cells were fixed for 10 min with 2.6% formaldehyde followed by permeabilisation with 0.4% Triton X-100 for 5 min at 4°C. After a quick PBS wash, cells were incubated with probes in a humid chamber overnight at 37°C. Xist RNA probes were generated from an 18 kb fragment spanning the whole Xist transcript using a nick translation kit (Abbott Molecular) as previously described ([@bib41]). Labeled RNA probes (1.5 μL) were co-precipitated with 10 μg salmon sperm DNA, 1/10 volume 3 M sodium acetate (pH 5.2) and 3 vol ethanol. After washing in 75% ethanol, the pellet was dried, resuspended in 6 μL formamide and denatured at 75°C for 7 min before flash cooling on ice. Probes were diluted in 6 μL 2x hybridization buffer (5x SSC, 12.5% dextran sulfate, 2.5 mg/mL BSA (NEB)), added to the slide/coverslips and incubated overnight at 37°C in a humid chamber. After incubation, slides/coverslips were washed three times with a solution of 2xSSC/50% formamide followed by three washes with 2xSSC in a water bath at 42°C. Slides/coverslips were mounted and sealed as for immunofluorescence.

### DNA-FISH on metaphase spreads {#sec4.4.17}

Metaphase spreads prepared on slides were de-hydrated in 75%, 80%, and 100% ethanol for 2 min at RT, denatured in 50% formamide/2xSSC at 65°C for 5 min, and de-hydrated again in ice-cold 75% ethanol for 2 min, followed by another 2 min in 80%, and 100% at 25°C. Xist probes were prepared as for RNA-FISH. Once the probes were added to the slides, another 3 min of denaturation at 65°C were performed before over-night incubation at 37°C in a humid chamber. After incubation, slides were washed three times with a solution of 2xSSC/50% formamide followed by three washes with 2xSSC in a water bath at 42°C. Slides were mounted and sealed as for immunofluorescence.

### ImmunoFISH {#sec4.4.18}

RNA FISH was performed essentially as previously described. Cells grown on slides or coverslips were washed in PBS, and fixed with 4% formaldehyde for 10 min before permeabilisation in 0.4% Triton X- 100 for 5 min. After washing in PBS, slides were incubated with 50% formamide in 2xSSC for 2 hr. Washes were performed twice in 50% formamide in 2x SSC for 3 min at 42°C, twice in 2xSSC for 3 min at 42°C and twice in PBS at room temperature. Slides were subsequently blocked in 0.2% fish gelatine (Sigma) three times for 10 min each, and primary antibodies were added in 0.2% fish gelatine and 5% normal goat serum in PBS. The slides were then processed in an identical manner to the immunofluorescence protocol detailed above.

### Hyperactive Tn5 production and ATAC-see {#sec4.4.19}

Hyperactive Tn5 protein production was achieved as previously described ([@bib13]). The fluorophore-conjugated adaptors (Life Technology) carry an Alexa-594 fluorophore (Resource Table). The assembly of Tn5 transposome was obtained with the following components: 0.1 vol annealed oligos (50 μM each double-stranded), 0.12 vol 2x Tn5 Dialysis buffer containing DTT, 0.34 vol Glycerol (100%), 0.1 vol purified Tn5 transposases (20 μM in stock) and 0.34 vol Nuclease-Free water. The solution was left on the bench at room temperature for 1 hr. Cells for ATAC-see were seeded on coverslips, and induced with doxycycline for 24 hr. Subsequently, a modified protocol for Xist RNA-FISH (described above) was employed, where immediately after permeabilisation, coverslips were washed once in PBS and incubated at 37°C for 1 hr with a transposase mixture solution (10 μL 5 × TD buffer, final concentration of 100 nM Tn5-Alexa, adding dH2O up to 50 μL). After the transposase reaction, slides were washed with PBS three times, and RNA-FISH continued as above.

### ATAC-seq sample preparation and sequencing {#sec4.4.20}

Chromatin accessibility was assayed using an adapted version of the Assay for Transposase Accessible Chromatin- (ATAC)-seq. Briefly, 10 million cells treated with doxycycline and the same number of matching untreated controls were harvested, washed with PBS and nuclei were isolated in 1 mL HS Lysis buffer (50 mM KCl, 10 mM MgSO~4~·7H~2~O, 5 mM HEPES, 0.05% NP40, 1 mM PMSF, 3 mM DTT) containing protease inhibitors (Roche) for 1 min at room temperature and on ice for further 3 min. Nuclei were centrifuged at 1000 g for 5 min at 4°C, and washed three times with ice-cold RSB buffer (10 mM NaCl, 10 mM Tris (pH 7.4), 3 mM MgCl~2~). 50,000 nuclei were resuspended in Tn5 reaction buffer (10 mM TAPS, 5 mM MgCl2, 10% dimethylformamide), 2.5 μL of home-made Tn5 transposase (20 μM in stock), and incubated at 37°C for 30 min. The tagmented DNA was purified with ChIP DNA Clean & Concentrator. ATAC-seq libraries were prepared by PCR amplification (12-13 cycles), using custom Illumina barcodes as previously described ([@bib8]) and NEBNext High-Fidelity 2X PCR Master Mix. Libraries were purified with three rounds of Agencourt AMPure XP bead cleanup (0.5X, 1.1X, 1.1X) to remove out-of-size fragments, and quantified by qPCR using KAPA Library Quantification DNA standards. ATAC-seq libraries were sequenced on Illumina NextSeq500 using 80 bp paired-end reads in biological duplicates.

### Microscopy {#sec4.4.21}

Z stack images were acquired with a DeltaVision system (Applied Precision) with a 1003/1.40 NA objective (Olympus) and de-convolved using the SoftWorx software algorithm (Applied Precision, conservative ratio method, 10 iterations). Best exposure time for each field and channel was manually determined and used for all subsequent experiments. Further image editing and refinement was achieved through Fiji/ImageJ.

### 4sU-RNA Immunoprecipitation {#sec4.4.22}

4sU-RNA was generated and isolated essentially as described in ([@bib49]). In detail, 4-thiouridine (4sU, Sigma, T4509) was dissolved in sterile PBS and stored at −20°C. 4sU was thawed just before use and added to the cells in the growing media at a concentration of 500 μM. Cells were incubated with the 4sU-supplemented medium for 12 min. Cell culture medium was rapidly removed from cells and 5 mL of Trizol reagent (Life Technologies) was added. Total RNA was extracted as described above, treated with DNase using the Ambion DNA-free DNase Treatment kit (Life Technologies) according to the manufacturer's instructions, and resuspended in water. For each μg of total RNA, 2 μL of Biotin-HPDP (Pierce, 50mg EZ-Link Biotin-HPDP), previously dissolved in DMF at a concentration of 1 mg/mL, and 1 μL of 10xBiotinylation buffer (100 mM Tris HCl pH 7.4, 10 mM EDTA), was added. The reaction was incubated with rotation for 15 min at 25°C. RNA was transferred to Phase Lock Gel Heavy Tubes (Eppendorf), and an equal volume of chloroform was added. After vigorously mixing, tubes were left incubating for 3 min at 25°C and then centrifuged at 13,000rpm for 5 min at 4°C. The upper phase was transferred to new Phase Lock Gel Heavy Tubes, and chloroform added again. After further centrifugation, the upper phase was transferred to a tube containing an equal volume of isopropanol and 1/10 volume of 5 M NaCl. After inversion, the tubes were centrifuged at 13,000 rpm for 20 min at 4°C. Pellet was washed in 75% ethanol and resuspended in water.

Biotinylated 4sU-RNA was recovered using the μMacs Streptavidin Kit (Miltenyi), with a modified protocol. Per μg of recovered biotynilated 4sU-RNA, 0.5 μL of streptavidin beads were added, in a total volume of 200 μL. Samples were incubated with rotation for 15 min at 25°C. μMacs columns supplied with the μMacs Streptavidin Kit were equilibrated in 1 mL of washing buffer (100 mM Tris HCl pH 7.5, 10 mM EDTA, 1 M NaCl, 0.1% Tween 20) at 65°C. Samples were added to the columns that were then washed 6 times with washing buffer, 3 times at 65°C and three times at 25°C. RNA was eluted in freshly-prepared 100 mM DTT. RNA was further purified using the RNA Mini Clean & Concentrator kit (Zymoresearch) according to the manufacturer's guidelines. 1 μL of 4sU-labeled RNA was quality-checked using the Agilent RNA 6000 Pico kit (Agilent technologies) according to the manufacturer's instructions, and run on a 2100 Bioanalyzer Instrument (Agilent).

### 4sU-seq library preparation and sequencing {#sec4.4.23}

Libraries for RNA-seq were constructed using TruSeq Stranded Total RNA Library Prep Kit (Illumina), with the incorporation of dUTP in the second strand synthesis, and sequenced at the GeneCore facility (EMBL, Heidelberg) using either Illumina HiSeq2000 or Illumina NextSeq500 sequencers.

### Xist *in vitro* transcription {#sec4.4.24}

RNAs were transcribed from a T7 promoter, following linearization with excess of PvuI-HF (NEB). 1 μg of DNA was in vitro transcribed using the HiScribe T7 High Yield RNA Synthesis Kit (NEB), according to the manufacturer's guidelines. In the reaction 1 μL of Biotin-16-dUTP (Sigma) was added, at a concentration of 50 μM. The size of the RNA was checked on a 1% agarose gel electrophoresed in MOPS buffer (0.2 M MOPS pH 7.0, 0.05 M Na acetate, 0.005 M EDTA pH 8.0). Before loading on the gel, 0.5 μg of each RNA sample, were diluted into 5xMOPS buffer, in the presence of 20 μL of formamide and 7 μL of 37% formaldehyde, and heated at 68°C for 15 min.

### RNA purification {#sec4.4.25}

In vitro transcribed RNA was diluted in a final volume of 100 μL, treated with DNase using the Ambion DNA-free DNase Treatment kit (Life Technologies) according to the manufacturer's instructions, and resuspended in water. DNA-free RNA was subsequently added to Phase Lock Gel Heavy Tubes (Eppendorf), with an equal volume of chloroform. After vigorously mixing, tubes were left incubating for 3 min at 25°C and then centrifuged at 13,000 rpm for 5 min at 4°C. The upper phase was transferred to normal tubes containing an equal volume of isopropanol and 1/10 volume of 5 M NaCl. After inversion, the tubes were centrifuged at 13,000 rpm for 20 min at 4°C. Supernatant was washed in 75% ethanol and resuspended in water.

### RNA slot blot {#sec4.4.26}

500 ng of each RNA sample were diluted into 10 μL, and mixed with 20 μL of formamide, 7 μL of 37% formaldehyde, 2 μL of 20xSSC. Tubes were heated at 68°C for 15 min, chilled on ice and diluted in 2 volumes of 20xSCC. Samples were then loaded on a blotter, and transferred onto an Amersham Hybond-XL nylon membrane (GE Healthcare). RNA was then UV cross-linked to the membrane using the optimal crosslink setting on a Stratalinker (120,000 μJ/cm2). The membrane was blocked by incubation for 1 hr at room temperature in 10 mL TBS, 0.1% Tween (TBST) with 5% w/v Marvel milk powder, and incubated for 1 hr at 25°C with Neutravidin-HRP antibody, washed 4 times for 10 min with TBST and visualized using ECL (GE Healthcare).

### Isolation of RNA templates and bound proteins {#sec4.4.27}

Nuclear extracts (15 μg) from PGK12.1 cells were incubated with 10 μg of each RNA in the presence of 5 μL RNasin Ribonuclease Inhibitors overnight at 4°C in 1 mL total volume of incubation buffer (150 mM NaCl, 15 mM Tris HCl (pH 7.5), 0.5 mM EDTA-NaOH, pH 8.0, 0.025% NP-40, with complete protease inhibitors (Roche) + 1 mM DTT added fresh). Samples were transferred to a tissue culture 6-well plate on ice, and UV cross-linked using a Stratalinler at 250,000 mJ/cm2. Samples were transferred back to protein LoBind micro-centrifuge tubes (Eppendorf), and 50 μL of M-280 Streptavidin Dynabeads (ThermoFisher) were added to each of them. Tubes were incubated with rotation at 4°C overnight. Flowthrough was collected for further analysis, whereas beads were washed 2 times in wash buffer A (150 mM NaCl, 15 mM Tris HCl (pH 7.5), 0.5 mM EDTA-NaOH, pH 8.0 with complete protease inhibitors (Roche) + 1 mM DTT added fresh), 2 times in wash buffer B (450 mM NaCl, 15 mM Tris HCl pH 7.5, 0.5 mM EDTA-NaOH, pH 8.0, 0.025% NP-40, 0.05% SDS, with complete protease inhibitors (Roche) + 0.1 mM DTT added fresh), and 2 times in wash buffer C (150 mM NaCl, 15 mM Tris HCl pH 7.5, 0.5 mM EDTA-NaOH, pH 8.0, with complete protease inhibitors (Roche)). Elution was performed in elution buffer (15 mM Tris HCl pH 7.5, 0.02% SDS) for 15 min at 65°C.

### Mass spectrometry {#sec4.4.28}

Peptides were resuspended in 5% formic acid and 5% DMSO and then trapped on a C18 PepMap100 pre-column (300 μm i.d. x 5 mm, 100 Å, Thermo Fisher Scientific) using 0.1% formic acid in water at a pressure of 500 bar and analyzed on an Ultimate 3000 UHPLC system (Thermo Fischer Scientific) coupled to a QExactive mass spectrometer (Thermo Fischer Scientific). The peptides were separated on an in-house packed analytical column (50 cm x 75 μm i.d. packed with ReproSil-Pur 120 C18-AQ, 1.9 μm, 120 Å) and then electrosprayed directly into an QExactive mass spectrometer (Thermo Fischer Scientific) through an EASY-Spray nano-electrospray ion source (Thermo Fischer Scientific) using a linear gradient (length: 60 min, 7% to 28% solvent B (0.1% Formic acid in acetonitrile), flow rate: 200 nL/minute). The raw data was acquired on the mass spectrometer in a data-dependent mode (DDA). Full scan MS spectra were acquired in the Orbitrap (scan range 350-2000 m/z, resolution 70000, AGC target 3xe6, maximum injection time 100 ms). After the MS scans, the 20 most intense peaks were selected for HCD fragmentation at 30% of normalized collision energy. HCD spectra were also acquired in the Orbitrap (resolution 17500, AGC target 5xe^4^, maximum injection time 120 ms) with first fixed mass at 180 m/z. The raw data files generated were processed using MaxQuant (Version 1.5.0.35), integrated with the Andromeda search engine as previously described. To identify protein groups, peak lists were searched against mouse database as well as list of common contaminants by Andromeda. Trypsin with a maximum number of missed cleavages of 2 was chosen. Acetylation (Protein N-term, i.e., only the n-terminus of the protein), Oxidation (M) and Phosphorylation (S, T and Y) were used as variable modifications while Carbamidomethylation (C) was set as a fixed modification. Protein and PTM false discovery rate (FDR) were set at 0.01 and a minimum score of 40 and localization probability of 0.7 for phospho-peptides. Match between runs was applied.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Polymorphic sites between 129S1 and CAST mouse genomes {#sec4.5.1}

Polymorphic sites (only SNPs, not indels) for 129S1 and Cast mouse strains were annotated based on the Sanger Mouse Genome Project, using the GRC38/mm10 genome assembly (dbSNP142). 5,878,742 and 22,603,978 high quality SNPs were reported for 129S1 and Cast genomes, respectively. The polymorphic sites between 129S1 and Cast were directly compared, resulting in a total of 23,005,850 polymorphic sites between the genomes. By comparing each genome with the C57BL/6J reference genome, 25,726,959 polymorphic sites were found to be present in both 129S1 and Cast genome sequences, and were therefore employed to generate an 'N-masked' genome sequence. Although only 41.17% (9471317) SNPs are annotated in genic regions (the mouse genome annotation was downloaded from GENOCDE_vM8), 96.74% of annotated transcripts contain at least one SNP site. Among the genic SNPs, 8,803,708 (92.95%) SNPs are located in intronic regions.

### 4sU-seq analysis {#sec4.5.2}

The raw fastq files of read pairs were first mapped to rRNA build, then the remaining unmapped reads were aligned to the 'N-masked' genome with STAR using the parameters '--outFilterMultimapNmax 1 --outFilterMismatchNmax 2 --alignEndsType EndToEnd' for all the 4sU-seq libraries ([@bib22]). Unique alignments were retained for further analysis. We employed the SNPsplit to separate the alignment into distinct alleles (Cast and 129S1) with the paired mode. The summary of the allelic split is listed in [Table S2](#mmc3){ref-type="supplementary-material"}. To call the allelic gene expression, the number of unique mapped read pairs for each annotated gene (CPM) was counted using the HT-seq ([@bib2]) with the parameters "-t transcript --s reverse," then normalizing to million mapped read pairs (library size) with edgeR R package, and then splitting the CPM value by the G1 (Cast.) or G2 (129S1) ratio. Cast Allelic expression is CPM ^∗^ G1/(G1+G2); 129S1 allelic expression is CPM ^∗^ G2/(G1+G2). Here G1 or G2 is the number of allele-specific read pairs. The genes whose expression level was on average above one in each sample were kept for further analysis (for libraries of time-course 4sU-seq of full-length Xist RNA, only the genes whose expression value sum over the complete time course from Cast and 129S1 alleles was more than 8 were kept; while for the experiments of various truncated Xist RNA, the threshold was set to 6). For visualization of RNA-seq data in UCSC genome browser, the coverage was generated by Bedtools (v2.17.0) ([@bib48]) and was normalized to 10 million mapped reads.

### Definition and Calculation of the Repression Score (RS) {#sec4.5.3}

Based on the assumption that transcriptional variation affects the alleles equally, the Repression Score (RS) of each gene was defined as:$$\text{RS} = \frac{Yi - Y0}{Y0} - \frac{Xi - X0}{X0}$$

Where, 'X' and 'Y' represent the value of gene expression for 129S1 or Cast alleles, respectively. '0' represents the untreated condition (no dox) of each experiment, while 'i' represents the treated condition (72 hr treatment or time-course treatment of 24, 48, or 72 h). Given that the repression score (RS) for the majority of genes is between 0 and 1, all repression scores larger than 1 were set to 1, while all repression scores lower than 0 were set to 0. In regards to Cast versus 129S1, we iterated our genome wide analysis of RS assuming that the integration event occurred in either the Cast or 129 genome, and then selected the best fit. The chromosome in which the largest number of genes showed significant allele-specific repression was defined as being subject to Xist-mediated silencing. RS for the silent alleles were subsequently compared pairwise to all other chromosomes.

For measuring silencing efficiency across the chromosome, sequential 10 Mb bin windows were used. The distribution of the RS was therefore compared between windows across the maximum-silenced chromosome. The maximum silencing region within the chromosome was determined as the region containing maximum repression score. The analysis was further refined by narrowing the windows to 5 Mb and 3 Mb windows. In order to minimize the gene expression variabilities in response to dox treatment, a calibrated Repression Score (cRS) was also defined. First, random Repression Score (rRS) was defined for the candidate allele either in independent control cell lines (used for precise silencing comparison for EvXist), or in all the other alleles of the analyzed cell line. cRS was calculated by subtraction of rRS from the RS: cRS = RS - rRS.

To evaluate the statistical significance of the RS for different cell lines harboring Xist transgenes, a p value based on a permutation method was designed and applied to each gene. Reads from the corresponding counts files were randomly sampled (NoDox and Dox treatment) and assigned to the Cast or 129S1 alleles on the basis of a binomial distribution. Repression Score (RS~null~) was calculated based on the permutated reads counts, and permutated N (N = 10000) times. The p value was defined as the fraction of RS~null~ which was no less than RS~obs~ (*i.e.* sum(ifelse(RS~null~\> = RS~obs~,1,0))/N, N = 10000). The permutation scheme was applied chromosome-wide. The p value for two biological replicates was calculated separately and then combined based on Fisher's method. q-values represent combined p values after adjustment following the Benjamini-Hochberg multiple testing in R. Definition of a "silent gene" is based on both the calibrated RS and q-value (q \< 0.05).

All the custom scripts, and pipeline used in this study are available at <https://github.com/guifengwei/XCI>. PCA analysis was based on the repression score of genes on the silenced chromosomes (e.g., Chr11 for EvXist comparison) with FactoMineR R package (v1.35). All the heatmaps generated in this study were plotted using pheatmap R packages, and bubble plots using ggplot2.

### Microscopy and ATAC-See analysis {#sec4.5.4}

All images were edited and refined through Fiji/ImageJ, number of analyzed cells and biological replicates depend on the experiment are always referred to in the matching figure legend. For ATAC-see analysis, a minimum of 20 cells were analyzed in triplicate as follows: a ROI was manually designed around the Xist domain in the stack where its intensity was the most prominent. ATAC signal was subsequently averaged for 6 stacks around the selected stack, and intensity compared between the Xist ROI and the entire nucleus (segmented based on DAPI signal). Significance was calculated using a paired two tailed Student's t test.

### ATAC-seq data analysis {#sec4.5.5}

The raw paired-end reads were mapped to 'N_masked' mm10 genome with STAR (2.4.2a) ([@bib22]) using the same parameters used for 4sU-seq analysis except "--alignIntronMax 10." The unique alignments were kept for the further analysis. SNPsplit was employed to assign the reads allele-specifically. The bedGraph files containing the library-size (10 million mapped reads) normalized differences between G1 (Cast.) and G2 (129S1) for each biological replicate were generated by Bedtools ([@bib48]). The differences between Dox and NoDox treatment were defined as follows:$$\text{ddscore} = \left\lbrack {\text{G}1\left( \text{Dox} \right) - \text{G}2\left( \text{Dox} \right)} \right\rbrack - \left\lbrack {\text{G}1\left( \text{NoDox} \right) - \text{G}2\left( \text{NoDox} \right)} \right\rbrack$$

The ddscore was stored in bedGraph format. For the functional *cis*-elements across the chromosomes, the pre-defined ChromHMM state (<https://github.com/guifengwei/ChromHMM_mESC_mm10>) across chr2 and chr3 was used. The average ddscores were calculated to represent the state across the corresponding chromosome.

### Mass spectrometry analysis {#sec4.5.6}

For the Xist A+B+ interactome, all hits annotated as contaminants by the Andromeda research engine were rejected. Subsequently all identified hits were compared with those identified as Xist A-B- interactors. The reported protein intensity was subtracted between the lists, and only the hits showing a \> 1 difference, were further analyzed as potential A- or B-repeat binders by comparing their intensity to that measured in the Xist A-B+, and Xist A+B- experiments, respectively. Data before and after filtering can be found in [Table S1](#mmc2){ref-type="supplementary-material"}.

Data and Software Availability {#sec4.6}
------------------------------

Original unprocessed gel images in this manuscript have been deposited to Mendeley Data and are available following these links: [https://doi.org/10.17632/p8835bsb8g.1](10.17632/p8835bsb8g.1){#intref0075}, [https://doi.org/10.17632/dfrbvsdcrf.1](10.17632/dfrbvsdcrf.1){#intref0080}.

The high-throughput data reported in this study have been deposited in GEO under accession number [GSE103370](ncbi-geo:GSE103370){#intref0085}.
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